|
|
|
|
UPDATE 1-Novo Nordisk says Victoza cleared for EU market
COPENHAGEN, July 3 (Reuters) - Danish pharmaceuticals group Novo Nordisk's diabetes drug Victoza, a key driver for future sales, has won European Commission approval for marketing across the European Union, the company said...
|
|
|
UPDATE 1-Novo Nordisk says Victoza cleared for EU market
COPENHAGEN, July 3 (Reuters) - Danish pharmaceuticals group Novo Nordisk's diabetes drug Victoza, a key driver for future sales, has won European Commission approval for marketing across the European Union, the company said...
|
|
|
UPDATE 1-Novo Nordisk says Victoza cleared for EU market
* Diabetes treatment Victoza gets EU marketing approval * Approval was expected after EU drugs agency recommendation * Launch planned for this year and in 2010 * Novo says approval does not change 2009 outlook (Adds details, quotes, share...
|
|
|
UPDATE 1-Novo Nordisk says Victoza cleared for EU market
COPENHAGEN, July 3 (Reuters) - Danish pharmaceuticals group Novo Nordisk's diabetes drug Victoza, a key driver for future sales, has won European Commission approval for marketing across the European Union, the company said...
|
|
|
UPDATE: Novo Nordisk Diabetes Drug Victoza Gets EU Approval
Danish pharmaceutical company Novo Nordisk A/S (NOVO-B.KO) said Friday the European Commission has given market authorization for its closely-watched diabetes treatment Victoza in the 27 European Union member states.Novo...
|
|
|
UPDATE: Novo Nordisk Diabetes Drug Victoza Gets EU Approval
(Adds detail, analyst and CSO comments.) Danish pharmaceutical company Novo Nordisk A/S (NOVO-B.KO) said Friday the European Commission has given market authorization for its closely-watched diabetes treatment Victoza in the 27 ...
|
|
|
Novo Nordisk's Victoza gets EU market green light
COPENHAGEN, July 3 (Reuters) - Danish pharmaceuticals group Novo Nordisk's diabetes treatment Victoza has won European Commission approval for marketing across the EU, the company said on Friday.'The European ...
|
|
|
AstraZeneca Receives European Authorisation for IRESSA Cancer Drug
AstraZeneca's oral anti-cancer drug Iressa has been granted marketing authorisation by the European Commission.Iressa is used for the treatment of adults with locally advanced or metastatic non-small cell lung cancer, with...
|
|
|
::: Novo Nordisk's Victoza (liraglutide) receives marketing authorisation in Europe
Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza for the treatment of type 2 diabetes in adults.The authorisation covers all 27 European Union member states.
|
|
|
Novo Nordisk's diabetes drug Victoza gets European OK
Novo Nordisk has been boosted by the news this morning that its diabetes drug Victoza has been approved by regulators in Europe.The Danish drugmaker says that the European Commission has granted marketing authorisation for...
|
|
|
Novo Nordisk A/S -- Regulatory Approval
(MARKETWIRE via COMTEX) -- Novo Nordisk's Victoza(R) (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza(R) for the...
|
|
|
Novo Nordisk A/S -- Regulatory Approval
Novo Nordisk's Victoza(R) (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza(R) for the treatment of type 2 diabetes...
|
|
|
Novo Nordisk A/S -- Regulatory Approval
(MARKETWIRE via COMTEX) -- NVO | Quote | Chart | News | PowerRating -- Novo Nordisk's Victoza(R) (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted...
|
|
|
Novo Nordisk A/S -- Regulatory Approval
(MARKETWIRE via COMTEX News Network) -- Novo Nordisk's Victoza(R) (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza...
|
|
|
Novo Nordisk A/S -- Regulatory Approval
Nordisk's Victoza (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza for the treatment of type 2 diabetes in adults....
|
|
|
Novo Nordisk A/S -- Regulatory Approval
BAGSVAERD, DENMARK, Jul 03 (MARKET WIRE) -- Novo Nordisk's Victoza(R) (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for...
|
|
|
Novo Nordisk A/S -- Regulatory Approval
BAGSVAERD, DENMARK, Jul 03 (MARKET WIRE) -- Novo Nordisk's Victoza(R) (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for...
|
|
|
Regulatory Approval
Novo Nordisk's Victoza (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza for the treatment of type 2 diabetes in...
|
|
|
Novo Nordisk A/S -- Regulatory Approval
Novo Nordisk's Victoza (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza for the treatment of type 2 diabetes in...
|
|
|
Novo Nordisk A/S -- Regulatory Approval
Novo Nordisk's Victoza(R) (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza(R) for the treatment of type 2 diabetes...
|
|
|
Novo Nordisk A/S -- Regulatory Approval
BAGSVAERD, DENMARK -- (Marketwire) -- 07/03/09 -- Novo Nordisk's Victoza (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for...
|
|
|
Novo Nordisk A/S -- Regulatory Approval
Novo Nordisk's Victoza (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza for the treatment of type 2 diabetes in...
|
|
|
Novo Nordisk A/S -- Regulatory Approval
Novo Nordisk's Victoza (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza for the treatment of type 2 diabetes in...
|
|
|
Novo Nordisk A/S -- Regulatory Approval
- Novo Nordisk's Victoza (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza for the treatment of type 2 diabetes in...
|
|
|
Novo Nordisk A/S: Novo Nordisk A/S -- Regulatory Approval
SOURCE: Novo Nordisk A/S BAGSVAERD, DENMARK--(Marketwire - July 3, 2009) - Novo Nordisk's Victoza (liraglutide) receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted...
|
